• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

我们对 SLC 和 ABC 药物转运体在儿童体内的药物处理了解多少?

How much do we know about drug handling by SLC and ABC drug transporters in children?

机构信息

Department of Pediatrics, University of California-San Diego, La Jolla, California, USA.

出版信息

Clin Pharmacol Ther. 2013 Jul;94(1):27-9. doi: 10.1038/clpt.2013.82.

DOI:10.1038/clpt.2013.82
PMID:23778708
Abstract

Although solute carrier (SLC) and ATP-binding cassette (ABC) transporters are critical to the absorption, distribution, and elimination of many small-molecule drugs in children, how these transporters regulate pediatric drug handling remains unclear. For proper dosing and to diminish toxicity, we need a better understanding of how organ development and functional maturation, as well as developmental changes in systemic physiology, impact transporter-mediated drug handling at pediatric developmental stages from the preterm infant through adolescence.

摘要

尽管溶质载体 (SLC) 和 ATP 结合盒 (ABC) 转运蛋白对于许多小分子药物在儿童体内的吸收、分布和消除至关重要,但这些转运蛋白如何调节儿童的药物处理仍不清楚。为了正确给药和降低毒性,我们需要更好地了解器官发育和功能成熟以及全身生理学的发育变化如何影响从早产儿到青春期的儿科发育阶段中转运蛋白介导的药物处理。

相似文献

1
How much do we know about drug handling by SLC and ABC drug transporters in children?我们对 SLC 和 ABC 药物转运体在儿童体内的药物处理了解多少?
Clin Pharmacol Ther. 2013 Jul;94(1):27-9. doi: 10.1038/clpt.2013.82.
2
Human Ontogeny of Drug Transporters: Review and Recommendations of the Pediatric Transporter Working Group.药物转运体的人类个体发育:儿科转运体工作组的综述与建议
Clin Pharmacol Ther. 2015 Sep;98(3):266-87. doi: 10.1002/cpt.176.
3
Transporters in human platelets: physiologic function and impact for pharmacotherapy.人血小板中的转运体:生理功能及其对药物治疗的影响。
Blood. 2012 Apr 12;119(15):3394-402. doi: 10.1182/blood-2011-09-336933. Epub 2012 Feb 14.
4
What do drug transporters really do?药物转运体到底在做什么?
Nat Rev Drug Discov. 2015 Jan;14(1):29-44. doi: 10.1038/nrd4461. Epub 2014 Dec 5.
5
Overview: Role of Drug Transporters in Drug Disposition and Its Clinical Significance.概述:药物转运体在药物处置中的作用及其临床意义。
Adv Exp Med Biol. 2019;1141:1-12. doi: 10.1007/978-981-13-7647-4_1.
6
ABC and SLC transporter expression and proton oligopeptide transporter (POT) mediated permeation across the human blood--brain barrier cell line, hCMEC/D3 [corrected].ABC 和 SLC 转运体表达和质子寡肽转运体(POT)介导的人血脑屏障细胞系 hCMEC/D3[校正]的渗透。
Mol Pharm. 2010 Aug 2;7(4):1057-68. doi: 10.1021/mp900178j.
7
Transporters in drug development and clinical pharmacology.药物研发和临床药理学中的转运体。
Clin Pharmacol Ther. 2013 Jul;94(1):3-9. doi: 10.1038/clpt.2013.86.
8
Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense.多药耐药蛋白:P-糖蛋白、多药耐药相关蛋白1、多药耐药相关蛋白2和乳腺癌耐药蛋白(ABCG2)在组织防御中的作用
Toxicol Appl Pharmacol. 2005 May 1;204(3):216-37. doi: 10.1016/j.taap.2004.10.012.
9
Antitubercular Agent Delamanid and Metabolites as Substrates and Inhibitors of ABC and Solute Carrier Transporters.抗结核药物地拉米啶及其代谢物作为ABC转运蛋白和溶质载体转运蛋白的底物和抑制剂
Antimicrob Agents Chemother. 2016 May 23;60(6):3497-508. doi: 10.1128/AAC.03049-15. Print 2016 Jun.
10
Drug transporters in drug efficacy and toxicity.药物转运体与药物疗效和毒性。
Annu Rev Pharmacol Toxicol. 2012;52:249-73. doi: 10.1146/annurev-pharmtox-010611-134529. Epub 2011 Sep 19.

引用本文的文献

1
TICBase: Integrated Resource for Data on Drug and Environmental Chemical Interactions with Mammalian Drug Transporters.TICBase:药物与环境化学物质与哺乳动物药物转运体相互作用数据的综合资源库。
Clin Pharmacol Ther. 2023 Dec;114(6):1293-1303. doi: 10.1002/cpt.3036. Epub 2023 Sep 12.
2
Potential implications of DMET ontogeny on the disposition of commonly prescribed drugs in neonatal and pediatric intensive care units.DMET 个体发育对新生儿和儿科重症监护病房常用药物处置的潜在影响。
Expert Opin Drug Metab Toxicol. 2021 Mar;17(3):273-289. doi: 10.1080/17425255.2021.1858051. Epub 2021 Jan 20.
3
Population Pharmacokinetic Properties of Antituberculosis Drugs in Vietnamese Children with Tuberculous Meningitis.
越南结核性脑膜炎患儿抗结核药物的群体药代动力学特性
Antimicrob Agents Chemother. 2020 Dec 16;65(1). doi: 10.1128/AAC.00487-20.
4
The Effect of Absorption-Enhancement and the Mechanism of the PAMAM Dendrimer on Poorly Absorbable Drugs.树状高分子聚酰胺(PAMAM)对吸收不良药物的增溶作用及其机制的研究。
Molecules. 2018 Aug 10;23(8):2001. doi: 10.3390/molecules23082001.
5
Developmental regulation of kidney and liver solute carrier and ATP-binding cassette drug transporters and drug metabolizing enzymes: the role of remote organ communication.肾脏和肝脏溶质载体和 ATP 结合盒药物转运体以及药物代谢酶的发育调控:远程器官通讯的作用。
Expert Opin Drug Metab Toxicol. 2018 Jun;14(6):561-570. doi: 10.1080/17425255.2018.1473376. Epub 2018 Jun 4.
6
Handling of Drugs, Metabolites, and Uremic Toxins by Kidney Proximal Tubule Drug Transporters.肾脏近端小管药物转运体对药物、代谢产物和尿毒症毒素的处理
Clin J Am Soc Nephrol. 2015 Nov 6;10(11):2039-49. doi: 10.2215/CJN.02440314. Epub 2015 Oct 21.
7
The organic anion transporter (OAT) family: a systems biology perspective.有机阴离子转运体(OAT)家族:系统生物学视角
Physiol Rev. 2015 Jan;95(1):83-123. doi: 10.1152/physrev.00025.2013.
8
What do drug transporters really do?药物转运体到底在做什么?
Nat Rev Drug Discov. 2015 Jan;14(1):29-44. doi: 10.1038/nrd4461. Epub 2014 Dec 5.
9
Characterization of the population pharmacokinetics of ampicillin in neonates using an opportunistic study design.利用机会性研究设计对新生儿氨苄西林群体药代动力学进行表征。
Antimicrob Agents Chemother. 2014 Jun;58(6):3013-20. doi: 10.1128/AAC.02374-13. Epub 2014 Mar 10.
10
Hepatocyte nuclear factors 4α and 1α regulate kidney developmental expression of drug-metabolizing enzymes and drug transporters.肝细胞核因子 4α 和 1α 调节药物代谢酶和药物转运体在肾脏发育中的表达。
Mol Pharmacol. 2013 Dec;84(6):808-23. doi: 10.1124/mol.113.088229. Epub 2013 Sep 13.